ArticleBMC gastroenterology2022

Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study.

Ji Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.